<DOC>
	<DOCNO>NCT01597180</DOCNO>
	<brief_summary>The purpose trial learn potential interaction raltegravir birth control pill HIV+ woman . The investigator plan enroll HIV+ woman steady state raltegravir contain highly active antiretroviral therapy ( HAART ) , age 20-40 , inclusive , report regular monthly menses . The investigator investigate drug interaction raltegravir , ethinyl estradiol ( EE ) levonorgestrel ( LNG ) . All woman receive raltegravir part regular medical care . Women enrol study approximately 8 month .</brief_summary>
	<brief_title>Pharmacokinetics , Pharmacodynamics Cervicovaginal Lavage Combined Oral Contraceptives Raltegravir</brief_title>
	<detailed_description />
	<mesh_term>Contraceptives , Oral</mesh_term>
	<mesh_term>Contraceptive Agents</mesh_term>
	<mesh_term>Raltegravir Potassium</mesh_term>
	<mesh_term>Contraceptives , Oral , Combined</mesh_term>
	<criteria>Women 2040 year age regular monthly menses If age 35 must use tobacco Negative pregnancy test No known allergy raltegravir No known history phenylketonuria Undetectable HIV viral load No active liver disease determine medical history normal AST ALT No history hepatic adenoma , carcinomas benign liver tumor Ho history thrombophlebitis thromboembolic disease No history deep vein thrombosis No history cerebral vascular coronary artery disease No known suspect carcinoma breast No undiagnosed abnormal genital bleed Not take concomitant CYP 450 induce medication antiseizure medication No use oral contraceptive , depotmedroxyprogesterone acetate , contraceptive ring patch within two month screen No cholestatic jaundice pregnancy jaundice prior contraceptive pill use Has use raltegravir prior screen Has history malignancy genital tract ( e.g . cervical cancer , ovarian cancer , endometrial cancer ) Must abnormal pap test define without resolution last 18 month .</criteria>
	<gender>Female</gender>
	<minimum_age>20 Years</minimum_age>
	<maximum_age>40 Years</maximum_age>
	<verification_date>March 2014</verification_date>
	<keyword>contraception</keyword>
	<keyword>HIV</keyword>
	<keyword>pharmacokinetics</keyword>
	<keyword>pharmacodynamics</keyword>
</DOC>